Latest News

• share
• favorite_border

2011 Pulitzer Prize winner to discuss his ‘biography’ of the disease with patients, survivors.

• share
• favorite_border

Latest results of Phase 2 study confirm high rate of response, remission

• share
• favorite_border

Signal tells MCM7 to launch DNA replication; pathway reduces breast cancer patient survival

• share
• favorite_border

Adults can avoid cancer-causing agents when they barbecue by using the healthy grilling tips in the new infographic, “How to fill a healthy barbecue plate,” created by experts at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

MET protein levels correlate strongly with epithelial-mesenchymal transition (EMT) phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Gene panel may help personalize therapy for aggressive brain tumors.

• share
• favorite_border

The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life.

• share
• favorite_border

Medal of honor goes to pioneer and leader in the field of cancer metastasis.

• share
• favorite_border

With tumor suppressors frozen in adolescence, resistant cancer cells cheat death, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports in Nature.

• share
• favorite_border

MD Anderson is leading efforts to better understand the mechanisms behind the obesity-cancer connection, how obesity impacts cancer treatment outcomes and novel methods of prevention to curb cancer risk. Following a multidisciplinary approach, with various specialties and departments coming together to piece together this complex puzzle, researchers focus on obesity across the entire cancer continuum, from prevention to survivorship.

• share
• favorite_border

Cancer Prevention Center to be named in honor of Dallas philanthropist.

• share
• favorite_border

Study shows potential impact of neighborhood environment on residents’ body fat.

• share
• favorite_border

MD Anderson oncologist leads program to study delivery, quality and cost of health care.

• share
• favorite_border

Researchers identify Peli1 as pivotal actor in animal model of multiple sclerosis.

• share
• favorite_border

John Mendelsohn, M.D., director of The University of Texas MD Anderson Cancer Center’s Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy and former president of MD Anderson, has been elected as a fellow of the American Academy of Arts and Sciences.

• share
• favorite_border

Union with Shc keeps potential troublemaker away from bad company and out of the nucleus.

• share
• favorite_border

For her research focusing on the refinement of predictive biomarkers and improving outcomes in the field of metastatic colorectal cancer, Maria Pia Morelli, M.D., Ph.D., has been awarded the 2013 Fight Colorectal Cancer-AACR Fellowship, in memory of Lisa Dubow.

• share
• favorite_border

Lung cancer expert who connects lab and clinic will lead research and academic programs.

• share
• favorite_border

AACR-Minorities in Cancer Research bestows Jane Cooke Wright Lectureship Award

• share
• favorite_border

Discoverer of drug to treat T cells, not tumors, receives inaugural AACR-CRI Lloyd J. Old Award in Cancer Immunology

• share
• favorite_border

West Texas fundraiser celebrates 27 years of support for UT MD Anderson Cancer Center .

• share
• favorite_border

Sixth Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research.

• share
• favorite_border

Guillermina “Gigi” Lozano, Ph.D., chair and professor in the Department of Genetics at The University of Texas MD Anderson Cancer Center, is the recipient of the 16th annual Women in Cancer Research Charlotte Friend Memorial Lectureship awarded by The American Association for Cancer Research (AACR), recognizing her contributions to the field of cancer research and the advancement of women in science.

• share
• favorite_border

Genes p63, p73 can fill in to identify, destroy bad cells if they can be protected from themselves.

• share
• favorite_border

MD Anderson Leukemia chair excels as clinical investigator, mentor and leader

• share
• favorite_border

Study shows metabolite biomarker could improve spiral CT screening, help detect disease early.

• share
• favorite_border

April 29 A Conversation With a Living Legend® benefits brain cancer research at MD Anderson.

• share
• favorite_border

Cancer center appoints first scientific director and co-director of the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research

• share
• favorite_border

Award will provide advanced instrumentation to unlock the secrets of pancreatic cancer metabolism

• share
• favorite_border

Fidler, Hong, Kripke, Mendelsohn and Strong earn cancer research group’s new honor.

• share
• favorite_border

Varenicline reduces depressive mood, craving and reward value of cigarettes when smokers attempt to quit

• share
• favorite_border

Selected for its ability to target tumors precisely while minimizing damage to healthy surrounding tissue, proton therapy has rapidly gained a foothold as an option for radiation treatment in the past decade. The Proton Therapy Center at The University of Texas MD Anderson Cancer Center in Houston, Texas, continues to innovate the field by being the first and only center in North America to treat patients with the most advanced form of proton therapy, called intensity modulated proton therapy with multi-field optimization (IMPT).

• share
• favorite_border

Home-based intervention finds those with improved self-efficacy work out longer.

• share
• favorite_border

Adults can learn how to increase their daily consumption of whole grains by using a new whole grain infographic created by experts at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Pro Football Hall of Fame member and "Dancing with the Stars" champion Emmitt Smith will be the honoree of the sixth annual A Conversation With a Living Legend luncheon, Monday, April 29, benefiting The University of Texas MD Anderson Cancer Center. The luncheon will be held at the Hilton Americas hotel in downtown Houston.

• share
• favorite_border

Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

• share
• favorite_border

Helen Piwnica-Worms, Ph.D., a leader and scientist whose success in cancer research spans the spectrum from basic science discovery through arduous preclinical follow up and delivery of potential new drugs to clinical trial, will lead science research at The University of Texas MD Anderson Cancer Center starting June 1.

• share
• favorite_border

Physician-scientist David Piwnica-Worms, M.D., Ph.D. whose creative and pioneering approach to visually capturing molecular processes in action has made him a leader in the field, will assume two important leadership posts at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Adults can learn how to choose snacks that offer more cancer-fighting nutrients by using the new healthy snack combo infographic, created by experts at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

• share
• favorite_border

Scientists who built a synthetic gene circuit that allowed for the precise tuning of a gene's expression in yeast have now refined this new research tool to work in human cells, according to research published online in Nature Communications.

• share
• favorite_border

Researchers employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease.

• share
• favorite_border

Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.

• share
• favorite_border

Blood vessels that supply oxygen and nutrients to tumors can also deliver something else - a signal that strengthens nearby cancer cells, making them more resistant to chemotherapy, more likely to spread to other organs and more lethal, scientists at The University of Texas MD Anderson Cancer Center report online in Cancer Cell.

• share
• favorite_border

Beta blockers inhibit cancer progression, decrease mortality.

• share
• favorite_border

Researchers from The University of Texas MD Anderson Cancer Center have found qigong, an ancient mind-body practice, reduces depressive symptoms and improves quality of life in women undergoing radiotherapy for breast cancer.

• share
• favorite_border

Prototype drug stabs membranes to kill microbes that cause pneumonia, sepsis, other infections.

• share
• favorite_border

Marked for death with molecular tags that act like a homing signal for a cell’s protein-destroying machinery, a pivotal enzyme is rescued by another molecule that sweeps the telltale targets off in the nick of time.

• share
• favorite_border

From a single cell gone bad, cancer evolves into an increasingly complex tumor built of a variety of normal cells and diverse malignant cells, some of which escape to create dangerous colonies in other organs, further jumbling the treatment picture.